The January Approach

Building upon the finding that protein-based nano-formulations drive substantial improvements in the efficacy of known drugs, our goal is to create novel drugs with superior efficacy and reduced toxicity in hard-to-treat malignancies.

January-process

January Albumin-Drug Nanoparticles typically allow:

  • Preferential tumor targeting over non-diseased tissue
  • Significantly improved intravenous dosing vs. unmodified drug
  • Potential for expanded clinical utility and ultimately wider potential treatment indications

January Therapeutics

11575 Sorrento Valley Rd., Suite 200
San Diego, CA 92121
Copyright 2018